Roche Holding AG (RHHBF)
OTCMKTS
· Delayed Price · Currency is USD
340.00
-12.00 (-3.41%)
Jun 27, 2025, 2:28 PM EDT
Roche Holding AG Company Description
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions.
The company was founded in 1896 and is based in Basel, Switzerland.
Roche Holding AG
| Country | Switzerland |
| Founded | 1896 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 103,249 |
| CEO | Thomas Schinecker |
Contact Details
Address: Grenzacherstrasse 124 Basel, 4070 Switzerland | |
| Phone | 41 61 688 88 80 |
| Website | roche.com |
Stock Details
| Ticker Symbol | RHHBF |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | CHF |
| ISIN Number | CH0012032113 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Thomas Schinecker | Group Chief Executive Officer |
| Dr. Severin Schwan Ph.D. | Executive Chairman |
| Dr. Alan Hippe | Chief Financial Officer |
| Dr. Bruno Eschli | Head of Investor Relations |
| Claudia Bockstiegel | General Counsel |
| Pascale Schmidt | Chief Compliance Officer |
| Barbara Schadler | Head of Group Communications |
| Cristina A. Wilbur | Chief People Officer |
| Dr. Nicolas Dunant | Head of Group Media Relations |
| Boris L. Zaitra | Head of Corporate Business Development |